STAT

MAY 2, 2023

Early in the Covid-19 pandemic, before we had vaccines and effective medical procedures, the only ways to prevent transmission of the virus were behavioral measures like face masks and social distancing. There was (and continues to be) a desperate hunger for definitive studies telling us how well specific measures would work, with specific publics, in specific settings, for specific strains of the novel and changing virus.

Vaccines 337

Vaccines 337

PharmaVoice

MAY 2, 2023

What’s so different about doing pharma business in the U.K. versus Japan? One of Moderna’s top brass shares her tips for navigating choppy cultural waters.

264

264

STAT

MAY 2, 2023

In 2004, the physician search firm Merritt Hawkins first issued their Survey of Physician Appointment Wait Times. That year, the national average wait to get in to see a new physician was 21 days, an unacceptable amount of time to wait to access care. But that number has only gotten worse. In their 2022 survey , the wait for a new patient appointment increased to an average of 26 days.

281

281

PharmaVoice

MAY 2, 2023

Martine van Vugt, recently named Genmab’s chief strategy officer and executive vice president, aims to usher in the company’s next wave of "knock your socks off" antibodies.

242

242

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

MAY 2, 2023

Eli Lilly is nearing the readout from a pivotal study of its experimental treatment for Alzheimer’s disease. The approval of a similar medicine earlier this year has wrung risk from the outcome, but for the same reason, expectations for strong results are higher. The Lilly drug, called donanemab, is an antibody that targets accumulated plaques in the brain called amyloid.

275

275

The Pharmacist

MAY 2, 2023

In Shilpa Shah’s area of North-East London, people ‘can't afford to be ill’. With many people accessing free prescriptions, community pharmacists in the area tend to give advice and recommend home remedies for self-limiting minor ailments, instead of over-the-counter treatments that patients would have to pay for. For a sore throat, patients might be told […] The post 'Utterly devastating’: Cost-of-living crisis hits OTC medicines access appeared first on The Pharmacist.

132

132

BioPharma Dive

MAY 2, 2023

Fresh off its success with the multiple myeloma treatment Carvykti, J&J is paying Cellular Biomedicine Group $245 million upfront for rights to two experimental cell therapies for blood cancer.

134

134

STAT

MAY 2, 2023

Many Black Americans would have to travel across county lines just to find an open spot with a cardiologist, a new analysis found. About 16.8 million Black Americans — roughly 1 in 3 — live in counties with little or no access to heart specialists, according to a report from GoodRx, a telehealth company that provides drug discounts and also researches health trends.

249

249

BioPharma Dive

MAY 2, 2023

The drugmaker beat Wall Street’s first quarter forecasts despite a sales drop that puts pressure on it to succeed with upcoming market launches.

Vaccines 134

Vaccines 134

STAT

MAY 2, 2023

CHICAGO — When internal medicine physician David Ansell started his career in 1978 at “County,” the sprawling public hospital that treated many of this city’s poorest residents, he didn’t question why so many of them were so sick, and their cases so complicated. “I just thought these were conditions they just had,” he said in a recent interview.

Hospitals 245

Hospitals Diabetes 245

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

European Pharmaceutical Review

MAY 2, 2023

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 1,2 In the EU, an estimated 2.7 million people are diagnosed with cancer annually and the number is growing. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients.

Clinical Pharmacology 101

Clinical Pharmacology Compounding Communication Pharmaceutical Companies 101

STAT

MAY 2, 2023

WASHINGTON — Widespread loneliness  in the U.S. poses health risks as deadly as smoking a dozen cigarettes daily, costing the health industry billions of dollars annually, the U.S. surgeon general said Tuesday in declaring the latest public health epidemic. About half of U.S. adults say they’ve experienced loneliness, Vivek Murthy said in a report from his office.

244

244

Pharmaceutical Technology

MAY 2, 2023

The US Food and Drug Administration (FDA) has accepted the supplemental biologics licence application submitted by Bristol Myers Squibb for Reblozyl (luspatercept-aamt) as a first-line treatment of anaemia in adults with lower-risk myelodysplastic syndromes (MDS). The regulatory body has also granted priority review to the application and set 28 August 2023 as a target date for the prescription drug user fee act (PDUFA).

Labelling 98

Labelling 98

STAT

MAY 2, 2023

The research question that pursued Jessica Valdez, an OB-GYN resident physician at the University of California, San Francisco, stemmed from her mother’s womb: How important is it to a birthing woman’s experience to be seen by health care providers who share her primary language? Valdez’s mother was 17 when she immigrated to California from Mexico in the 1970s.

225

225

PharmaState Academy

MAY 2, 2023

DATE: 04 – 06 December 2023 Venue: Dubai, UAE PharmaState Academy has announced its collaboration with the Pharmaceutical Conference 2023 as a media partner. This highly esteemed event is all set to take place in Dubai, UAE, and will be the eighth edition of the conference. It promises to be an extraordinary three-day event that will bring together industry experts, researchers, and practitioners from around the world.

98

98

STAT

MAY 2, 2023

WASHINGTON — There’s a new bill in Congress meant to crack down on the cheap disposable vapes, like Puff Bar, that are increasingly popular with kids. But nearly all of the leading tobacco-control groups don’t want anything to do with it. They say the bill is being pushed by the makers of competing vapes, namely RJ Reynolds, the maker of Vuse e-cigarettes, to take attention off of its products’ growing popularity, and to push competition out of business.

220

220

The Pharmacist

MAY 2, 2023

People in Lithuania have placed lit candles outside community pharmacies to symbolise mourning, after parliamentarians voted to allow remote supervision – a move that campaigners fear would spell the death of the pharmacist profession. On Tuesday 25 April 2023, 64 members of the Seimas (Lithuanian parliament) voted to allow pharmacy technicians who qualified before 2006 […] The post Candles lit in Lithuania to mourn loss of pharmacist profession appeared first on The Pharmacist.

Pharmacy Technician 94

Pharmacy Technician Community Pharmacies 94

STAT

MAY 2, 2023

A California jury was unable to reach a verdict in a messy, drawn-out legal battle between Apple and patient-monitoring company Masimo. James Selna, the judge presiding, announced the case a mistrial on Monday. “While we are disappointed that the jury was unable to reach a verdict, we intend to retry the case and continue to pursue legal redress against Apple,” Masimo told STAT in a statement.

208

208

BioPharma Dive

MAY 2, 2023

Shares in the biotech, formerly Retrophin, sank after the company disclosed its newly approved drug sparsentan failed a study meant to expand its use.

100

100

STAT

MAY 2, 2023

After years of sparring, the federal government and Gilead Sciences will square off in a Delaware courtroom this week in a bid to settle dueling claims over the rights to a pair of groundbreaking and lucrative HIV prevention pills. The case has drawn attention because a central theme is the extent to which taxpayer-funded research may be used by a pharmaceutical company to reap enormous profits, and whether the prices charged for any resulting medicine are out of reach for many Americans.

Pharmaceutical Companies 191

Pharmaceutical Companies Pharmaceutical Companies 191

European Pharmaceutical Review

MAY 2, 2023

The US Food and Drug Administration (FDA) has released a new draft guidance to further support the use of decentralised clinical trials (DCTs) for drugs, biologics and devices. The publication includes recommendations for sponsors, investigators and other stakeholders regarding the implementation of DCTs to advance medical product development and research.

Packaging 81

Packaging 81

Drug Channels

MAY 2, 2023

In my most recent video webinar , I explored how the rapid expansion of patient-paid prescriptions—via cash-pay pharmacies and discount card vendors—is transforming the prescription market. Below, I follow the dollar when a patient uses a discount card to pay for a generic drug prescription. As you’ll see, a discount card can save money for consumers by leveraging several quirks of U.S. retail pharmacy pricing.

73

73

PharmaTech

MAY 2, 2023

The use of smart tools in early drug discovery can have an impact on downstream phases of drug development.

Drug Development 98

Drug Development 98

Pharma Times

MAY 2, 2023

Deal involves an oral BET inhibitor which treats fibrotic and immuno-inflammatory disorders

89

89

PharmExec

MAY 2, 2023

Acquisition expected to support pharmaceutical’s blindness regeneration campaign.

98

98

Pharma Times

MAY 2, 2023

Duo have partnered on developing a biotherapeutic therapy for flu and COVID-19

91

91

Express Pharma

MAY 2, 2023

Laurus Labs announced the receipt of the USFDA tentative approval of their Oral Dispersible Film (ODF) Dolutegravir 5mg and 10mg for paediatric ARV treatment. A company release informed, “This paediatric drug administration through Oral Dispersible Film technology developed by Laurus Labs will simplify the drug administration in children. It will help in bringing a significant benefit in compliance with ARV medication in paediatric HIV treatment.

60

60

Pharmaceutical Technology

MAY 2, 2023

ODAIA, a life sciences predictive analytics and commercial insights provider, has secured an investment of $25m in its Series B funding round. The round was led by Threshold Ventures and co-led by Monograph Capital. Another new investor to take part in Series B round was Wittington Ventures. Existing investors including Flint Capital, StandUp Ventures, Graphite Ventures and BDC Capital’s Women in Technology Venture Fund, also participated in this round.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Vaccines 59

PharmaTech

MAY 2, 2023

Digital transformation to the Pharma 4.0 paradigm moves forward in process development and clinical and commercial manufacturing.

69

69

World Pharma News

MAY 2, 2023

Gene-editing therapy aimed at two targets - HIV-1, the virus that causes AIDS, and CCR5, the co-receptor that helps the virus get into cells - can effectively eliminate HIV infection, new research from the Lewis Katz School of Medicine at Temple University and the University of Nebraska Medical Center (UNMC) shows. The study, published online in the journal The Proceedings of the National Academy of Sciences (PNAS), is the first to combine a dual gene-editing strategy with antiretroviral drugs t

60

60

Drug Patent Watch

MAY 2, 2023

PROAIR DIGIHALER (albuterol sulfate) Teva branded pharm Patent: 7,540,282 Expiration: May 6, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,… The post Drug Patent Expirations for the Week of April 30, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma in Brief

MAY 2, 2023

The Standing Committee on Health ( HESA ) has begun a study on the Patented Medicine Prices Review Board ( PMPRB ). HESA is made up of 12 Members of Parliament representing the four main parties in the House of Commons. In connection with this study, HESA has conducted two meetings to ask questions of witnesses regarding the PMPRB: The first meeting on the PMPRB was held on Thursday, April 27.

52

52

PharmaTech

MAY 2, 2023

The new research and development capacities set the stage for completion of product development for LEON’s manufacturing devices and will be used to showcase the devices and provide process development services to clients using LEON’s equipment.

52

52

Express Pharma

MAY 2, 2023

Ahmedabad Pharma Summit 2023: Charting India Pharma Inc’s Growth Path Click to download: May 2023 Digital Magazine The post Express Pharma May 2023 appeared first on Express Pharma.

52

52

PharmaTech

MAY 2, 2023

This paper demonstrates how assay data sets of a formulated liquid product, drug substance, and an impurity, obtained from combined accuracy-precision studies, are evaluated to calculate statistical intervals (prediction and tolerance intervals) and to graphically display the total analytical error (TAE) to account for the systematic and random errors.

52

52